BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1472924)

  • 21. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
    Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
    Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma.
    Wu JZ; Tian T; Huang Y; Liang JH; Miao Y; Wang L; Xu J; Qu XY; Fan L; Li JY; Xu W
    Cancer Biomark; 2016 Jul; 17(2):205-12. PubMed ID: 27434288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse large cell lymphomas: identification of prognostic factors and validation of the International Non-Hodgkin's Lymphoma Prognostic Index. A Hellenic Cooperative Oncology Group Study.
    Nicolaides C; Fountzilas G; Zoumbos N; Skarlos D; Kosmidis P; Pectasides D; Karabelis A; Giannakakis T; Symeonidis A; Papadopoulos A; Antoniou F; Pavlidis N
    Oncology; 1998; 55(5):405-15. PubMed ID: 9732217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.
    Seymour JF; Talpaz M; Cabanillas F; Wetzler M; Kurzrock R
    J Clin Oncol; 1995 Mar; 13(3):575-82. PubMed ID: 7884418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
    Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors in primary gastric lymphoma.
    Medina-Franco H; Germes SS; Maldonado CL
    Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
    Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
    Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of concordant and discordant bone marrow involvement on outcome in diffuse large B-cell lymphoma treated with R-CHOP.
    Sehn LH; Scott DW; Chhanabhai M; Berry B; Ruskova A; Berkahn L; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 Apr; 29(11):1452-7. PubMed ID: 21383296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of C-reactive protein, lactase dehydrogenase and anemia in recurrent or refractory aggressive lymphoma.
    Suzuki K; Terui Y; Nishimura N; Mishima Y; Sakajiri S; Yokoyama M; Takahashi S; Tsuyama N; Takeuchi K; Hatake K
    Jpn J Clin Oncol; 2013 Jan; 43(1):37-44. PubMed ID: 23166385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β
    Montalbán C; Díaz-López A; Dlouhy I; Rovira J; Lopez-Guillermo A; Alonso S; Martín A; Sancho JM; García O; Sánchez JM; Rodríguez M; Novelli S; Salar A; Gutiérrez A; Rodríguez-Salazar MJ; Bastos M; Domínguez JF; Fernández R; Gonzalez de Villambrosia S; Queizan JA; Córdoba R; de Oña R; López-Hernandez A; Freue JM; Garrote H; López L; Martin-Moreno AM; Rodriguez J; Abraira V; García JF;
    Br J Haematol; 2017 Mar; 176(6):918-928. PubMed ID: 28106247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
    Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
    J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of infiltrating immune cells within bone marrow of patients with diffuse large B-cell lymphoma.
    Jeong J; Oh EJ; Yang WI; Kim SJ; Yoon SO
    Hum Pathol; 2017 Jun; 64():222-231. PubMed ID: 28438619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma.
    Shehata AMF; Aldesoky AI; Gohar SF
    Hematology; 2019 Dec; 24(1):103-107. PubMed ID: 30198830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large-cell lymphoma: a study of prognostic factors and assessment of five recently proposed predictive systems.
    Lopez-Guillermo A; Montserrat E; Reverter JC; Cervantes F; Escoda L; Tassies D; Blade J; Marin P; Sierra J; Ordi J
    Leuk Lymphoma; 1993 May; 10(1-2):101-9. PubMed ID: 8374517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma inhibiting activity protein (MIA), beta-2 microglobulin and lactate dehydrogenase (LDH) in metastatic melanoma.
    Cao MG; Auge JM; Molina R; Martí R; Carrera C; Castel T; Vilella R; Conill C; Sánchez M; Malvehy J; Puig S
    Anticancer Res; 2007; 27(1B):595-9. PubMed ID: 17348447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biological significance of serum tumor markers in adult T-cell leukemia.
    Sadamori N
    Leuk Lymphoma; 1996 Aug; 22(5-6):415-9. PubMed ID: 8882954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study.
    Yamamoto M; Watanabe K; Fukuda T; Miura O
    Anticancer Res; 2017 May; 37(5):2655-2662. PubMed ID: 28476841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia.
    Kantarjian HM; Smith T; Estey E; Polyzos A; O'Brien S; Pierce S; Beran M; Feldman E; Keating MJ
    Am J Med; 1992 Dec; 93(6):599-604. PubMed ID: 1466355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central nervous system involvement in diffuse large B-cell lymphoma.
    Yamamoto W; Tomita N; Watanabe R; Hattori Y; Nakajima Y; Hyo R; Hashimoto C; Motomura S; Ishigatsubo Y
    Eur J Haematol; 2010 Jul; 85(1):6-10. PubMed ID: 20236301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.
    Bartl R; Frisch B; Diem H; Mündel M; Fateh-Moghadam A
    Eur J Haematol Suppl; 1989; 51():88-98. PubMed ID: 2697597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.